Gladstone NOW: The Campaign Join Us on the Journey ✕
91 - 105 of 236 Results Clear All
USA Today—Senior investigator Warner Greene, MD, PhD, comments on the benefits of vaccination after COVID-19 illness.
Gladstone Experts COVID-19 Center for HIV Cure Research Infectious Disease Greene Lab
Gladstone researchers studied how T cells respond to COVID-19 vaccines over the weeks following immunization
News Release Research (Publication) COVID-19 Infectious Disease Roan Lab
Armed with a $26.5-million grant, a multi-institution collaboratory will tackle HIV in a new way
Grants News Release HIV/AIDS Infectious Disease Ott Lab CRISPR/Gene Editing
San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, draws from his expertise as a virologist to explain how Delta and other coronavirus variants might evolve.
COVID-19 Center for HIV Cure Research Infectious Disease Greene Lab
UCSF News—Associate Investigator Nadia Roan, PhD, explains why the coronavirus delta variant is so infectious, how antibodies and T cells contribute to immunity, and why vaccinated people should still wear masks.
Gladstone Experts COVID-19 Infectious Disease Roan Lab
COVID vaccines protect from serious illness but may not prevent vaccinated people from transmitting the delta variant. Gladstone Associate Investigator Nadia Roan, PhD, says that wearing a mask adds to the protective effect of vaccines and helps reduce the circulation of the highly contagious delta variant.
COVID-19 Infectious Disease Roan Lab
Gladstone researchers discover a fundamental mechanism that appears to speed the change of stem cells into other cell types
News Release Research (Publication) Infectious Disease Weinberger Lab Stem Cells/iPSCs Chaturvedi
Gladstone scientists have uncovered T-cell signatures that may help understand why some people succumb to severe COVID-19 while others recover
News Release Research (Publication) COVID-19 Infectious Disease Roan Lab Single Cell
New analysis suggests the California variant is more transmissible than unmutated strains, but vaccines are effective against it
News Release Research (Publication) COVID-19 Infectious Disease Ott Lab
Gladstone researchers have identified the blood cells most likely to be targeted by HIV during a real-life infection
News Release Research (Publication) HIV/AIDS Infectious Disease Roan Lab
ABC7 News—Senior Investigator Melanie Ott, PhD, Director of the Gladstone Institute of Virology, talks about the long path to leadership and recognition for women in medicine.
COVID-19 Infectious Disease Ott Lab
San Francisco Business Times—Senior Investigator Melanie Ott, MD, PhD, and Graduate Student Parinaz Fozouni explain how the CRISPR- and smartphone-based diagnostic platform they recently developed with UC Berkeley Dan Fletcher, PhD, and Nobel Laureate Jennifer Doudna, PhD, could allow low-cost and widespread testing and help to quickly curb the course of this and future pandemics.
COVID-19 Infectious Disease Doudna Lab Ott Lab CRISPR/Gene Editing
Gladstone scientists discover how the novel coronavirus damages heart muscle cells, and create a system that can be used to screen potential therapies
News Release Research (Publication) COVID-19 Cardiovascular Disease Infectious Disease Conklin Lab McDevitt Lab Ott Lab
The Mercury News—Director of Gladstone Institute of Virology Melanie Ott, MD, PhD, comments on the new coronavirus variants and says vaccines currently distributed in the US protect against hospitalization and death from COVID-19.
Gladstone Experts COVID-19 Infectious Disease Ott Lab
San Francisco Business Times—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, is one of several key Bay Area women life scientists sharing their views on their careers, the pandemic, and the path ahead for women leaders.
Gladstone Experts COVID-19 Infectious Disease Ott Lab
